Tyra Biosciences
(NASDAQ) TYRA
Tyra Biosciences Financials at a Glance
Market Cap
$1.58B
Revenue (TTM)
$0.00
Net Income (TTM)
-$131.11M
EPS (TTM)
-$2.17
P/E Ratio
-12.25
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$26.61
Volume
1,487,986.205
Open
$27.11
Price
$26.61
Volume
1,487,986.205
Open
$27.11
Previous Close
$26.64
Daily Range
$26.41 - $27.79
52-Week Range
$8.98 - $40.65
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$26.61
Volume
1,487,986.205
Open
$27.11
Previous Close
$26.64
Daily Range
$26.41 - $27.79
52-Week Range
$8.98 - $40.65
Estimated Earnings Date
Aug 13, 2026
TYRA News
TYRA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tyra Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
87
CEO
Todd J. Harris, PhD
Website
www.tyra.bioHeadquarters
Carlsbad, CA 92008, US
TYRA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-37%
Return on Capital
-36%
Return on Assets
-32%
Earnings Yield
-8.16%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.58B
Shares Outstanding
59.47M
Volume
1.49M
Avg. Volume
967.40K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$132.76M
EBITDA
-$132.22M
Operating Cash Flow
-$95.14M
Capital Expenditure
-$141.00K
Free Cash Flow
-$95.28M
Cash & ST Invst.
$256.00M
Total Debt
$5.81M
Tyra Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$138.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.58B
N/A
Market Cap/Employee
$26.40M
N/A
Employees
60
N/A
Net Income
-$39.31M
-39.6%
EBITDA
-$41.86M
-32.0%
Quarterly Fundamentals
Net Cash
$377.77M
+20.8%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$5.21M
-8.5%
Short Term Debt
$488.00K
+14.6%
Return on Assets
-31.82%
N/A
Return on Invested Capital
-36.38%
N/A
Free Cash Flow
-$32.66M
-28.2%
Operating Cash Flow
-$32.57M
-27.9%